BCL2 and cancer: In addition, it seems that these miRNAs influence the anti-cancer effects of silibinin through upregulation of putative targets such as P53, CASP9, APAF1, and BAX, as well as downregulation of genes such as BCL-2, CD34, AKT3, MASPINE, EGF, SERPINEA12, and BMP7.